アンチエイジング薬の世界及び中国市場

• 英文タイトル：Global and China Anti-aging Drugs Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8771 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の当調査資料ではグローバルにおけるアンチエイジング薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、アンチエイジング薬の種類別市場規模（皮膚充填剤、ボツリヌス毒素、その他）、用途別市場規模（病院、美容院、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のアンチエイジング薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるアンチエイジング薬の種類別市場規模（2016年-2027年）：皮膚充填剤、ボツリヌス毒素、その他 ・世界におけるアンチエイジング薬の用途別市場規模（2016年-2027年）：病院、美容院、その他 ・アンチエイジング薬の中国市場分析 - アンチエイジング薬の中国市場規模（2016年-2027年） - 中国におけるアンチエイジング薬の主要プレイヤー別市場シェア - 中国におけるアンチエイジング薬の種類別市場規模：皮膚充填剤、ボツリヌス毒素、その他 - 中国におけるアンチエイジング薬の用途別市場規模：病院、美容院、その他 ・アンチエイジング薬の北米市場（2016年-2027年） ・アンチエイジング薬のヨーロッパ市場（2016年-2027年） ・アンチエイジング薬のアジア太平洋市場（2016年-2027年） ・アンチエイジング薬の中南米市場（2016年-2027年） ・アンチエイジング薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Allergan、Galderma、LG Life Science、Merz Pharma、Medytox、Hugel、IMEIK、Haohai Bio、Daewoong Pharmaceutical、Bloomage、Suneva Medical、SciVision Biotech ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・...

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The industry’s leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.

Market Analysis and Insights: Global and China Anti-aging Drugs Market
This report focuses on global and China Anti-aging Drugs market.
In 2020, the global Anti-aging Drugs market size was US$ 7905.9 million and it is expected to reach US$ 17320 million by the end of 2027, with a CAGR of 11.9% during 2021-2027. In China the Anti-aging Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Anti-aging Drugs Scope and Market Size
Anti-aging Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-aging Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Anti-aging Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Dermal Fillers
Botulinum Toxin
Others

Segment by Application
Hospital
Beauty Parlor
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech

レポート目次

---

1 Study Coverage
1.1 Anti-aging Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-aging Drugs Market Size Growth Rate by Type
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti-aging Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Beauty Parlor
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Anti-aging Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-aging Drugs Revenue 2016-2027
2.1.2 Global Anti-aging Drugs Sales 2016-2027
2.2 Global Anti-aging Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anti-aging Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Anti-aging Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anti-aging Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anti-aging Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anti-aging Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Anti-aging Drugs Revenue Forecast by Region (2022-2027)

3 Global Anti-aging Drugs Competitor Landscape by Players
3.1 Global Top Anti-aging Drugs Manufacturers by Sales
3.1.1 Global Anti-aging Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Anti-aging Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anti-aging Drugs Manufacturers by Revenue
3.2.1 Key Anti-aging Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anti-aging Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Anti-aging Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anti-aging Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anti-aging Drugs Revenue in 2020
3.2.6 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-aging Drugs Price by Manufacturers
3.4 Global Anti-aging Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-aging Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-aging Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-aging Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Anti-aging Drugs Market Size by Type (2016-2021)
4.1.1 Global Anti-aging Drugs Sales by Type (2016-2021)
4.1.2 Global Anti-aging Drugs Revenue by Type (2016-2021)
4.1.3 Anti-aging Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anti-aging Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Anti-aging Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-aging Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Anti-aging Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Anti-aging Drugs Market Size by Application (2016-2021)
5.1.1 Global Anti-aging Drugs Sales by Application (2016-2021)
5.1.2 Global Anti-aging Drugs Revenue by Application (2016-2021)
5.1.3 Anti-aging Drugs Price by Application (2016-2021)
5.2 Anti-aging Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Anti-aging Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-aging Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-aging Drugs Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Anti-aging Drugs Market Size YoY Growth 2016-2027
6.1.1 China Anti-aging Drugs Sales YoY Growth 2016-2027
6.1.2 China Anti-aging Drugs Revenue YoY Growth 2016-2027
6.1.3 China Anti-aging Drugs Market Share in Global Market 2016-2027
6.2 China Anti-aging Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Anti-aging Drugs Players by Sales (2016-2021)
6.2.2 China Top Anti-aging Drugs Players by Revenue (2016-2021)
6.3 China Anti-aging Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Anti-aging Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Anti-aging Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Anti-aging Drugs Price by Type (2016-2021)
6.4 China Anti-aging Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Anti-aging Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Anti-aging Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Anti-aging Drugs Price Forecast by Type (2022-2027)
6.5 China Anti-aging Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Anti-aging Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Anti-aging Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Anti-aging Drugs Price by Application (2016-2021)
6.6 China Anti-aging Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Anti-aging Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Anti-aging Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Anti-aging Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Anti-aging Drugs Market Size YoY Growth 2016-2027
7.2 North America Anti-aging Drugs Market Facts & Figures by Country
7.2.1 North America Anti-aging Drugs Sales by Country (2016-2021)
7.2.2 North America Anti-aging Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Anti-aging Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anti-aging Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Anti-aging Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Anti-aging Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Anti-aging Drugs Market Size YoY Growth 2016-2027
9.2 Europe Anti-aging Drugs Market Facts & Figures by Country
9.2.1 Europe Anti-aging Drugs Sales by Country (2016-2021)
9.2.2 Europe Anti-aging Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Anti-aging Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Anti-aging Drugs Market Facts & Figures by Country
10.2.1 Latin America Anti-aging Drugs Sales by Country (2016-2021)
10.2.2 Latin America Anti-aging Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Anti-aging Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anti-aging Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-aging Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anti-aging Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Anti-aging Drugs Products Offered
12.1.5 Allergan Recent Development
12.2 Galderma
12.2.1 Galderma Corporation Information
12.2.2 Galderma Description and Business Overview
12.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Galderma Anti-aging Drugs Products Offered
12.2.5 Galderma Recent Development
12.3 LG Life Science
12.3.1 LG Life Science Corporation Information
12.3.2 LG Life Science Description and Business Overview
12.3.3 LG Life Science Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LG Life Science Anti-aging Drugs Products Offered
12.3.5 LG Life Science Recent Development
12.4 Merz Pharma
12.4.1 Merz Pharma Corporation Information
12.4.2 Merz Pharma Description and Business Overview
12.4.3 Merz Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merz Pharma Anti-aging Drugs Products Offered
12.4.5 Merz Pharma Recent Development
12.5 Medytox
12.5.1 Medytox Corporation Information
12.5.2 Medytox Description and Business Overview
12.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medytox Anti-aging Drugs Products Offered
12.5.5 Medytox Recent Development
12.6 Hugel
12.6.1 Hugel Corporation Information
12.6.2 Hugel Description and Business Overview
12.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hugel Anti-aging Drugs Products Offered
12.6.5 Hugel Recent Development
12.7 IMEIK
12.7.1 IMEIK Corporation Information
12.7.2 IMEIK Description and Business Overview
12.7.3 IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IMEIK Anti-aging Drugs Products Offered
12.7.5 IMEIK Recent Development
12.8 Haohai Bio
12.8.1 Haohai Bio Corporation Information
12.8.2 Haohai Bio Description and Business Overview
12.8.3 Haohai Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Haohai Bio Anti-aging Drugs Products Offered
12.8.5 Haohai Bio Recent Development
12.9 Daewoong Pharmaceutical
12.9.1 Daewoong Pharmaceutical Corporation Information
12.9.2 Daewoong Pharmaceutical Description and Business Overview
12.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Daewoong Pharmaceutical Anti-aging Drugs Products Offered
12.9.5 Daewoong Pharmaceutical Recent Development
12.10 Bloomage
12.10.1 Bloomage Corporation Information
12.10.2 Bloomage Description and Business Overview
12.10.3 Bloomage Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bloomage Anti-aging Drugs Products Offered
12.10.5 Bloomage Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Anti-aging Drugs Products Offered
12.11.5 Allergan Recent Development
12.12 SciVision Biotech
12.12.1 SciVision Biotech Corporation Information
12.12.2 SciVision Biotech Description and Business Overview
12.12.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 SciVision Biotech Products Offered
12.12.5 SciVision Biotech Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anti-aging Drugs Industry Trends
13.2 Anti-aging Drugs Market Drivers
13.3 Anti-aging Drugs Market Challenges
13.4 Anti-aging Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-aging Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Anti-aging Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dermal Fillers
Table 3. Major Manufacturers of Botulinum Toxin
Table 4. Major Manufacturers of Others
Table 5. Global Anti-aging Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Anti-aging Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Anti-aging Drugs Sales by Regions (2016-2021) & (K Units)
Table 8. Global Anti-aging Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Anti-aging Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Anti-aging Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Anti-aging Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Anti-aging Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Anti-aging Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Anti-aging Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Anti-aging Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Anti-aging Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Anti-aging Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Anti-aging Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Anti-aging Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-aging Drugs as of 2020)
Table 21. Key Manufacturers Anti-aging Drugs Price (2016-2021) (US$/Unit)
Table 22. Anti-aging Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti-aging Drugs Product Type
Table 24. Date of International Manufacturers Enter into Anti-aging Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-aging Drugs Sales by Type (2016-2021) (K Units)
Table 27. Global Anti-aging Drugs Sales Share by Type (2016-2021)
Table 28. Global Anti-aging Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Anti-aging Drugs Revenue Share by Type (2016-2021)
Table 30. Anti-aging Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Anti-aging Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Anti-aging Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Anti-aging Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Anti-aging Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Anti-aging Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Anti-aging Drugs Sales by Application (2016-2021) (K Units)
Table 37. Global Anti-aging Drugs Sales Share by Application (2016-2021)
Table 38. Global Anti-aging Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Anti-aging Drugs Revenue Share by Application (2016-2021)
Table 40. Anti-aging Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Anti-aging Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Anti-aging Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Anti-aging Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Anti-aging Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Anti-aging Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Anti-aging Drugs Sales (K Units) of Key Companies (2016-2021)
Table 47. China Anti-aging Drugs Sales Share by Company (2016-2021)
Table 48. China Anti-aging Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China Anti-aging Drugs Revenue Share by Company (2016-2021)
Table 50. China Anti-aging Drugs Sales (K Units) by Type (2016-2021)
Table 51. China Anti-aging Drugs Sales Share by Type (2016-2021)
Table 52. China Anti-aging Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Anti-aging Drugs Price (US$/Unit) by Type (2016-2021)
Table 54. China Anti-aging Drugs Sales (K Units) by Type (2022-2027)
Table 55. China Anti-aging Drugs Sales Share by Type (2022-2027)
Table 56. China Anti-aging Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Anti-aging Drugs Revenue Share by Type (2022-2027)
Table 58. China Anti-aging Drugs Price (US$/Unit) by Type (2022-2027)
Table 59. China Anti-aging Drugs Sales (K Units) by Application (2016-2021)
Table 60. China Anti-aging Drugs Sales Share by Application (2016-2021)
Table 61. China Anti-aging Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Anti-aging Drugs Price (US$/Unit) by Application (2016-2021)
Table 63. China Anti-aging Drugs Sales (K Units) by Application (2022-2027)
Table 64. China Anti-aging Drugs Sales Share by Application (2022-2027)
Table 65. China Anti-aging Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Anti-aging Drugs Revenue Share by Application (2022-2027)
Table 67. China Anti-aging Drugs Price (US$/Unit) by Application (2022-2027)
Table 68. North America Anti-aging Drugs Sales by Country (2016-2021) & (K Units)
Table 69. North America Anti-aging Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Anti-aging Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Anti-aging Drugs Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Anti-aging Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Anti-aging Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Anti-aging Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Anti-aging Drugs Sales by Country (2016-2021) & (K Units)
Table 77. Europe Anti-aging Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Anti-aging Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Anti-aging Drugs Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Anti-aging Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Anti-aging Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Anti-aging Drugs Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Anti-aging Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Anti-aging Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Anti-aging Drugs Revenue Market Share by Country (2016-2021)
Table 88. Allergan Corporation Information
Table 89. Allergan Description and Business Overview
Table 90. Allergan Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Allergan Anti-aging Drugs Product
Table 92. Allergan Recent Development
Table 93. Galderma Corporation Information
Table 94. Galderma Description and Business Overview
Table 95. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Galderma Product
Table 97. Galderma Recent Development
Table 98. LG Life Science Corporation Information
Table 99. LG Life Science Description and Business Overview
Table 100. LG Life Science Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. LG Life Science Product
Table 102. LG Life Science Recent Development
Table 103. Merz Pharma Corporation Information
Table 104. Merz Pharma Description and Business Overview
Table 105. Merz Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Merz Pharma Product
Table 107. Merz Pharma Recent Development
Table 108. Medytox Corporation Information
Table 109. Medytox Description and Business Overview
Table 110. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Medytox Product
Table 112. Medytox Recent Development
Table 113. Hugel Corporation Information
Table 114. Hugel Description and Business Overview
Table 115. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Hugel Product
Table 117. Hugel Recent Development
Table 118. IMEIK Corporation Information
Table 119. IMEIK Description and Business Overview
Table 120. IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. IMEIK Product
Table 122. IMEIK Recent Development
Table 123. Haohai Bio Corporation Information
Table 124. Haohai Bio Description and Business Overview
Table 125. Haohai Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Haohai Bio Product
Table 127. Haohai Bio Recent Development
Table 128. Daewoong Pharmaceutical Corporation Information
Table 129. Daewoong Pharmaceutical Description and Business Overview
Table 130. Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Daewoong Pharmaceutical Product
Table 132. Daewoong Pharmaceutical Recent Development
Table 133. Bloomage Corporation Information
Table 134. Bloomage Description and Business Overview
Table 135. Bloomage Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Bloomage Product
Table 137. Bloomage Recent Development
Table 138. Suneva Medical Corporation Information
Table 139. Suneva Medical Description and Business Overview
Table 140. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Suneva Medical Product
Table 142. Suneva Medical Recent Development
Table 143. SciVision Biotech Corporation Information
Table 144. SciVision Biotech Description and Business Overview
Table 145. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. SciVision Biotech Product
Table 147. SciVision Biotech Recent Development
Table 148. Anti-aging Drugs Market Trends
Table 149. Anti-aging Drugs Market Drivers
Table 150. Anti-aging Drugs Market Challenges
Table 151. Anti-aging Drugs Market Restraints
Table 152. Anti-aging Drugs Customers List
Table 153. Anti-aging Drugs Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-aging Drugs Product Picture
Figure 2. Global Anti-aging Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Dermal Fillers Product Picture
Figure 4. Botulinum Toxin Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-aging Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Beauty Parlor
Figure 9. Others
Figure 10. Anti-aging Drugs Report Years Considered
Figure 11. Global Anti-aging Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-aging Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Anti-aging Drugs Sales 2016-2027 (K Units)
Figure 14. Global Anti-aging Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Anti-aging Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global Anti-aging Drugs Sales Market Share by Region in 2020
Figure 17. Global Anti-aging Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global Anti-aging Drugs Revenue Market Share by Region in 2020
Figure 19. Global Anti-aging Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Anti-aging Drugs Revenue in 2020
Figure 21. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Anti-aging Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global Anti-aging Drugs Sales Market Share by Type in 2020
Figure 24. Global Anti-aging Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Anti-aging Drugs Revenue Market Share by Type in 2020
Figure 26. Global Anti-aging Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global Anti-aging Drugs Sales Market Share by Application in 2020
Figure 28. Global Anti-aging Drugs Revenue Market Share by Application (2016-2021)
Figure 29. Global Anti-aging Drugs Revenue Market Share by Application in 2020
Figure 30. China Anti-aging Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 31. China Anti-aging Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Anti-aging Drugs Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Anti-aging Drugs Players Market Share by Revenue in Anti-aging Drugs in 2020
Figure 34. China Anti-aging Drugs Revenue Share by Type (2016-2021)
Figure 35. China Anti-aging Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Anti-aging Drugs Revenue Share by Application (2016-2021)
Figure 37. China Anti-aging Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Anti-aging Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 39. North America Anti-aging Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Anti-aging Drugs Sales Market Share by Country in 2020
Figure 41. North America Anti-aging Drugs Revenue Market Share by Country in 2020
Figure 42. U.S. Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 43. U.S. Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 45. Canada Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Anti-aging Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 47. Europe Anti-aging Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Anti-aging Drugs Sales Market Share by Country in 2020
Figure 49. Europe Anti-aging Drugs Revenue Market Share by Country in 2020
Figure 50. Germany Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 51. Germany Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 53. France Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 55. U.K. Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 57. Italy Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 59. Russia Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Anti-aging Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 61. Asia Pacific Anti-aging Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Anti-aging Drugs Sales Market Share by Region in 2020
Figure 63. Asia Pacific Anti-aging Drugs Revenue Market Share by Region in 2020
Figure 64. China Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 65. China Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 67. Japan Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 69. South Korea Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 71. India Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 73. Australia Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 75. Taiwan Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 77. Indonesia Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 79. Thailand Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 81. Malaysia Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 83. Philippines Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 85. Vietnam Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Anti-aging Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Anti-aging Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Anti-aging Drugs Sales Market Share by Country in 2020
Figure 89. Latin America Anti-aging Drugs Revenue Market Share by Country in 2020
Figure 90. Mexico Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Anti-aging Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Anti-aging Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Anti-aging Drugs Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Anti-aging Drugs Revenue Market Share by Country in 2020
Figure 100. Turkey Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Anti-aging Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 105. UAE Anti-aging Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Anti-aging Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed

---